Gimatecan

CAS: 292618-32-7

Ref. 3D-SLA61832

Produktinformation

• Name: Gimatecan
• Synonyme: 1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-11-carboxaldehyde, 4-ethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-, 11-[O-(1,1-dimethylethyl)oxime], [C(E),4S]-, (S)-Gimatecan, 7-[(E)-t-Butyloxyiminomethyl]camptothecin, ST 1481

Beschreibung

Gimatecan is a cycle-specific inhibitor that targets kinases and proteins involved in cancer cell growth. It is a medicinal compound that has been shown to be effective against various types of human cancers. Gimatecan works by inhibiting the activity of protein kinases, which are enzymes that promote cell division and proliferation. This inhibition leads to apoptosis, or programmed cell death, in tumor cells. Gimatecan has been tested extensively in Chinese hamster ovary cells and has demonstrated potent anticancer activity. The compound is excreted primarily through urine and has shown promising results as an anticancer agent in preclinical studies.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 447.5 g/mol
• Formel: C₂₅H₂₅N₃O₅
• Reinheit: Min. 95%